Capital Advisory Group Advisory Services, LLC Gilead Sciences, Inc. Transaction History

Capital Advisory Group Advisory Services, LLC

$250 Million
Q3 2024

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$57.72 - $65.01 $484,732 - $545,953	-8,398 Closed	0 $0
Q1 2022 Apr 29, 2022	BUY	$57.92 - $72.58 $10,831 - $13,572	187 Added 2.28%	8,398 $499,000
Q4 2021 Feb 15, 2022	SELL	$64.88 - $73.64 $201,322 - $228,504	-3,103 Reduced 27.43%	8,211 $596,000
Q3 2021 Nov 12, 2021	BUY	$67.69 - $73.03 $45,081 - $48,637	666 Added 6.25%	11,314 $790,000
Q2 2021 Nov 12, 2021	BUY	$63.47 - $69.35 $234,902 - $256,664	3,701 Added 53.27%	10,648 $733,000
Q1 2021 May 14, 2021	SELL	$60.0 - $68.46 $2,880 - $3,286	-48 Reduced 0.69%	6,947 $449,000
Q4 2020 Feb 18, 2021	BUY	$56.65 - $64.55 $264,555 - $301,448	4,670 Added 200.86%	6,995 $408,000
Q3 2020 Nov 16, 2020	BUY	$62.1 - $78.08 $141,836 - $178,334	2,284 Added 5570.73%	2,325 $147,000
Q2 2020 Aug 14, 2020	BUY	$72.34 - $84.0 $1,374 - $1,596	19 Added 86.36%	41 $3,000
Q1 2020 May 18, 2020	BUY	$62.63 - $80.22 $1,377 - $1,764	22 New	22 $1,000
Q4 2019 Feb 14, 2020	SELL	$61.62 - $67.78 $1,355 - $1,491	-22 Closed	0 $0
Q1 2018 May 28, 2020	BUY	$72.84 - $88.8 $1,602 - $1,953	22 New	22 $1,000

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$11.1 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.7 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$7.07 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.71 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.56 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Advisory Group Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Advisory Group Advisory Services, LLC with notifications on news.

Account